PMC:7594251 / 254-449 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T7999","span":{"begin":104,"end":109},"obj":"Body_part"}],"attributes":[{"id":"A19488","pred":"fma_id","subj":"T7999","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"l a major challenge because pathogens rapidly and continually evolve developing drug resistance. Cancer cells also change genetically, and current therapeutic techniques may be (or may become) in"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T2","span":{"begin":97,"end":103},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"l a major challenge because pathogens rapidly and continually evolve developing drug resistance. Cancer cells also change genetically, and current therapeutic techniques may be (or may become) in"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T97528","span":{"begin":2,"end":3},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T35994","span":{"begin":104,"end":109},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"l a major challenge because pathogens rapidly and continually evolve developing drug resistance. Cancer cells also change genetically, and current therapeutic techniques may be (or may become) in"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":80,"end":84},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"l a major challenge because pathogens rapidly and continually evolve developing drug resistance. Cancer cells also change genetically, and current therapeutic techniques may be (or may become) in"}

{"project":"LitCovid-PubTator","denotations":[{"id":"10","span":{"begin":97,"end":103},"obj":"Disease"}],"attributes":[{"id":"A10","pred":"tao:has_database_id","subj":"10","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"l a major challenge because pathogens rapidly and continually evolve developing drug resistance. Cancer cells also change genetically, and current therapeutic techniques may be (or may become) in"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T77349","span":{"begin":80,"end":95},"obj":"http://purl.obolibrary.org/obo/GO_0042493"}],"text":"l a major challenge because pathogens rapidly and continually evolve developing drug resistance. Cancer cells also change genetically, and current therapeutic techniques may be (or may become) in"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":80,"end":95},"obj":"Phenotype"},{"id":"T2","span":{"begin":97,"end":103},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0020174"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"l a major challenge because pathogens rapidly and continually evolve developing drug resistance. Cancer cells also change genetically, and current therapeutic techniques may be (or may become) in"}